$139.20
-0.600 (-0.429%)
At Close: Aug 04, 2026
Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Sciencast Management LP
03:40pm, Sunday, 05'th Dec 2021 Dakota Financial News
Sciencast Management LP lifted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 323.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,461 shares of the medical research companys stock after acquiring an additional 16,392 shares during the period. Agilent []
Sciencast Management LP Grows Position in Agilent Technologies, Inc. (NYSE:A)
03:02pm, Sunday, 05'th Dec 2021 Dakota Financial News
Sciencast Management LP grew its position in Agilent Technologies, Inc. (NYSE:A) by 323.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,461 shares of the medical research companys stock after buying an additional 16,392 shares during the quarter. []
Insider Selling: Agilent Technologies, Inc. (NYSE:A) VP Sells 669 Shares of Stock
11:34am, Saturday, 04'th Dec 2021 Transcript Daily
Agilent Technologies, Inc. (NYSE:A) VP Rodney Gonsalves sold 669 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, November 30th. The stock was sold at an average price of $152.04, for a total transaction of $101,714.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is []
Robeco Institutional Asset Management B.V. Has $166.35 Million Holdings in Agilent Technologies, Inc. (NYSE:A)
05:08pm, Friday, 03'rd Dec 2021 Transcript Daily
Robeco Institutional Asset Management B.V. trimmed its stake in Agilent Technologies, Inc. (NYSE:A) by 10.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,055,958 shares of the medical research company’s stock after selling 122,787 shares during the period. Robeco Institutional Asset Management […]
Dividend Champions For December 2021
08:56pm, Thursday, 02'nd Dec 2021
Monthly update of the Dividend Champions List. 75 companies declared higher dividends in the past month, with an average increase of 8.55% over their previous payouts.
Worldwide Whole Genome and Exome Sequencing Industry to 2026 - Featuring 10x Genomics, Abbott Diagnostics and Agilent Among Others
03:15pm, Thursday, 02'nd Dec 2021 PR Newswire
DUBLIN, Dec. 2, 2021 /PRNewswire/ -- The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis - 2022 to 2026 " report has been added to ResearchAndMarkets.com''s offering. The COVID
According to the report, The global soil testing equipment market size was valued at $3.05 billion in 2020 and is expected to reach $6.99 billion by 2028 growing at the CAGR of 10.63% from 2021 to 2028. There are a
Mycoplasma Diagnostics Market To Rise At 10.6% CAGR During 20162024: TMR
11:25am, Thursday, 02'nd Dec 2021 OpenPR
The global mycoplasma infections diagnostics market is consolidated to a large extent with the leading five vendors jointly accounting for 68.0 % of the global market in 2016, notes Transparency Market Research (TMR). The leading companies are Lonza Group, Agilent
Fifth Third Bancorp Has $10.32 Million Stake in Agilent Technologies, Inc. (NYSE:A)
02:24pm, Wednesday, 01'st Dec 2021 Dakota Financial News
Fifth Third Bancorp decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 3.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 65,488 shares of the medical research companys stock after selling 2,136 shares during the quarter. Fifth Third Bancorps holdings in Agilent []
Global Prepacked Chromatography Columns market Overview Single-use innovations make manufacturing simpler with prepackaged chromatography columns. Equipment capital and qualification, asset traceability, calibration, and routine maintenance are all eliminated with these columns. Prepackaged chromatography columns often save money on materials and consumables associated
Biochip Technology Market Incredible Growth USD 17.75 billion with Agilent Technologies Inc., Fluidigm Corporation, PerkinElmer
11:52am, Wednesday, 01'st Dec 2021 OpenPR
A biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed at the same time in order to achieve higher throughput and speed. Biochip Technology Market is estimated to
Pacer Advisors Inc. Acquires 6,937 Shares of Agilent Technologies, Inc. (NYSE:A)
11:24am, Wednesday, 01'st Dec 2021 Dakota Financial News
Pacer Advisors Inc. increased its holdings in Agilent Technologies, Inc. (NYSE:A) by 24.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,505 shares of the medical research companys stock after acquiring an additional 6,937 shares during the period. []
Global Endocrine Testing Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com
10:46am, Wednesday, 01'st Dec 2021 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Endocrine Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com''s offering. The global endocrine testing market reached a value of US$ 10 Billion in 2020. Looking forward, the publisher expects the market to grow at a CAGR of 8.7% during 2021-2026. Companies Mentioned Abbott Laboratories Agilent Technologies Inc. Bio-Rad Laboratories Inc. BioMerieux SA DiaSorin S.p.A. F. Hoff
The global Cell Analysis Technology market size is projected to a CAGR of 14.2% during 2021-2027. Worldwide Cell Analysis Technology Market 2021-2027 industry report examines the development openings just as the dangers to the Cell Analysis Technology Market w.r.t Business
DNA microarrays are microscope slides that are printed with thousands of tiny spots in defined positions, with each spot containing a known DNA sequence or gene. The two mRNA samples are then converted into complementary DNA (cDNA), and each sample
Sign In
Buy A